Systems Biological Analysis of Epidermal Growth Factor Receptor Internalization Dynamics for Altered Receptor Levels*

Epidermal growth factor (EGF) receptor (EGFR) overexpression is a hallmark of many cancers. EGFR endocytosis is a critical step in signal attenuation, raising the question of how receptor expression levels affect the internalization process. Here we combined quantitative experimental and mathematical modeling approaches to investigate the role of the EGFR expression level on the rate of receptor internalization. Using tetramethylrhodamine-labeled EGF, we established assays for quantifying EGF-triggered EGFR internalization by both high resolution confocal microscopy and flow cytometry. We determined that the flow cytometry approach was more sensitive for examining large populations of cells. Mathematical modeling was used to investigate the relationship between EGF internalization kinetics, EGFR expression, and internalization machinery. We predicted that the standard parameter used to assess internalization kinetics, the temporal evolution r(t) of the ratio of internalized versus surface-located ligand·receptor complexes, does not describe a straight line, as proposed previously. Instead, a convex or concave curve occurs depending on whether initial receptor numbers or internalization adaptors are limiting the uptake reaction, respectively. To test model predictions, we measured EGF-EGFR binding and internalization in cells expressing different levels of green fluorescent protein-EGFR. As expected, surface binding of rhodamine-labeled EGF increased with green fluorescent protein-EGFR expression level. Unexpectedly, internalization of ligand· receptor complexes increased linearly with increasing receptor expression level, suggesting that receptors and not internalization adaptors were limiting the uptake in our experimental model. Finally, determining the ratio of internalized versus surface-located ligand·receptor complexes for this cell line confirmed that it follows a convex curve, supporting our model predictions.

[1]  D. Lauffenburger,et al.  Computational modeling of the EGF-receptor system: a paradigm for systems biology. , 2003, Trends in cell biology.

[2]  Toshio Yanagida,et al.  Single-molecule imaging of EGFR signalling on the surface of living cells , 2000, Nature Cell Biology.

[3]  Y. Yarden,et al.  Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases , 2001, FEBS letters.

[4]  L. Pelkmans,et al.  Not just a sink: endosomes in control of signal transduction. , 2004, Current opinion in cell biology.

[5]  P. Tan,et al.  Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors , 2009, Breast Cancer Research and Treatment.

[6]  Beverly Packard,et al.  DPSS yellow‐green 561‐nm lasers for improved fluorochrome detection by flow cytometry , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[7]  B. Kholodenko,et al.  Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades , 2004, The Journal of cell biology.

[8]  Y. Yarden,et al.  p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.

[9]  J. Welsh,et al.  Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. , 1990, Science.

[10]  H. Wiley,et al.  Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. , 1990, The Journal of biological chemistry.

[11]  I. Dikic,et al.  Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors , 2002, Nature.

[12]  G. Carpenter,et al.  All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*) , 1996, The Journal of Biological Chemistry.

[13]  Y. Teramura,et al.  Single‐molecule analysis of epidermal growth factor binding on the surface of living cells , 2006, EMBO Journal.

[14]  Lucas Pelkmans,et al.  Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae , 2005, Nature.

[15]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[16]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[17]  J. Post,et al.  Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.

[18]  H. Wiley,et al.  The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. , 1982, The Journal of biological chemistry.

[19]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[20]  Y. Yarden,et al.  ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.

[21]  Bianca Habermann,et al.  APPL Proteins Link Rab5 to Nuclear Signal Transduction via an Endosomal Compartment , 2004, Cell.

[22]  P. Transidico,et al.  Clathrin-independent endocytosis of ubiquitinated cargos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. McNiven,et al.  A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. , 2006, Cancer research.

[24]  C. Bräuchle,et al.  Cellular dynamics of EGF receptor-targeted synthetic viruses. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  A. Paller,et al.  Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. , 2007, Cancer research.

[26]  Joseph Schlessinger,et al.  Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor , 2002, Cell.

[27]  R. Langer,et al.  Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. , 2008, Cancer research.

[28]  S. Schmid,et al.  Regulation of signal transduction by endocytosis. , 2000, Current opinion in cell biology.

[29]  Peter Klein,et al.  On the nature of low- and high-affinity EGF receptors on living cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Mann,et al.  Phosphotyrosine interactome of the ErbB-receptor kinase family , 2005, Molecular systems biology.

[31]  Boris N. Kholodenko,et al.  Untangling the signalling wires , 2007, Nature Cell Biology.

[32]  F. Révillion,et al.  ERBB2 oncogene in human breast cancer and its clinical significance. , 1998, European journal of cancer.

[33]  Roland Eils,et al.  An ultrasensitive sorting mechanism for EGF Receptor Endocytosis , 2008, BMC Systems Biology.

[34]  Rick Chappell,et al.  Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. , 2004, International journal of radiation oncology, biology, physics.

[35]  P. Bastiaens,et al.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.

[36]  Qian Wang,et al.  Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation , 2005, EMBO reports.

[37]  S. Schmid,et al.  Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis , 1996, Science.

[38]  A. Sorkin,et al.  EGF receptor ubiquitination is not necessary for its internalization , 2007, Proceedings of the National Academy of Sciences.

[39]  H. Wiley,et al.  Receptor-mediated endocytosis in Xenopus oocytes. I. Characterization of the vitellogenin receptor system. , 1987, The Journal of biological chemistry.

[40]  A. Citri,et al.  EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.

[41]  Eytan Domany,et al.  A module of negative feedback regulators defines growth factor signaling , 2007, Nature Genetics.

[42]  B. Geiger,et al.  Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency* , 1998, The Journal of Biological Chemistry.

[43]  P. Bastiaens,et al.  Prolonged EGFR Signaling by ERBB2‐Mediated Sequestration at the Plasma Membrane , 2008, Traffic.

[44]  Vladislav V Verkhusha,et al.  New lasers for flow cytometry: filling the gaps , 2007, Nature Methods.

[45]  Pier Paolo Di Fiore,et al.  Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation , 2003, Nature Cell Biology.

[46]  J. Isola,et al.  Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival , 2006, Neuropathology and applied neurobiology.

[47]  H. Wiley,et al.  Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system , 1988, The Journal of cell biology.

[48]  H Steven Wiley,et al.  Trafficking of the ErbB receptors and its influence on signaling. , 2003, Experimental cell research.

[49]  S. Tripp,et al.  Epidermal Growth Factor Receptor Gene Amplification and Protein Expression in Glioblastoma Multiforme: Prognostic Significance and Relationship to Other Prognostic Factors , 2006, Applied immunohistochemistry & molecular morphology : AIMM.

[50]  R. Tsien,et al.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.

[51]  L. E. Johannessen,et al.  EGF‐Induced Activation of the EGF Receptor Does Not Trigger Mobilization of Caveolae , 2006, Traffic.

[52]  A. Lenferink,et al.  Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.